Institutional Ownership Regeneron Pharmaceuticals, Inc. (REGN)
This table provides information about the institutional ownership of Regeneron Pharmaceuticals, Inc. (REGN). We have compiled data on the 1,495 institutions that hold shares in the stock, with a total of 85.9 Million shares, which have been reported (via 13F filing form) to have a value of $57.8 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Capital Investment Counsel, Inc
|
Feb 03, 2025 Q4 2024 |
288
shares
|
$193,639
0.03% of portfolio
|
Q3 2023
Reduced 30.27%
|
|
|
Waldron Private Wealth LLC
|
Jan 23, 2025 Q4 2024 |
288
shares
|
$193,639
0.01% of portfolio
|
Q4 2024
Reduced 21.31%
|
|
|
Schear Investment Advisers, LLC
Cincinnati, OH |
Jan 29, 2025 Q4 2024 |
288
shares
|
$193,639
0.11% of portfolio
|
Q4 2024
Reduced 23.81%
|
|
|
Wealthcare Advisory Partners LLC
West Chester, PA |
Jan 15, 2025 Q4 2024 |
287
shares
|
$192,967
0.01% of portfolio
|
Q4 2024
Reduced 3.69%
|
|
|
Custom Index Systems, LLC
New York, NY |
Jan 23, 2025 Q4 2024 |
286
shares
|
$192,294
0.11% of portfolio
|
Q4 2024
Added 0.35%
|
|
|
Pacific Sage Partners, LLC
Shoreline, WA |
Jan 24, 2025 Q4 2024 |
285
shares
|
$191,622
0.05% of portfolio
|
Q2 2024
Added 0.35%
|
|
|
Clarendon Private LLC
Boston, MA |
Jan 21, 2025 Q4 2024 |
283
shares
|
$190,277
0.21% of portfolio
|
Q4 2024
New holding
|
|
|
Syntax Advisors, LLC
New York, NY |
Nov 13, 2023 Q3 2023 |
282
shares
|
$189,605
0.4% of portfolio
|
Q3 2023
Reduced 8.14%
|
|
|
Ronald Blue Trust, Inc.
Brentwood, TN |
Jan 30, 2025 Q4 2024 |
280
shares
|
$188,260
0.0% of portfolio
|
Q4 2024
Reduced 61.33%
|
|
|
Penserra Capital Management LLC
Orinda, CA |
Feb 13, 2025 Q4 2024 |
276
shares
|
$185,571
0.0% of portfolio
|
Q4 2024
Added 2966.67%
|
|
|
Tfc Financial Management
|
Jan 29, 2025 Q4 2024 |
272
shares
|
$182,881
0.03% of portfolio
|
Q4 2024
Added 3.03%
|
|
|
Lipe & Dalton
|
Feb 03, 2025 Q4 2024 |
269
shares
|
$180,864
0.1% of portfolio
|
Q2 2023
Reduced 6.92%
|
|
|
Core Cap Advisors, LLC
Southfield, MI |
Feb 14, 2025 Q4 2024 |
266
shares
|
$178,847
0.01% of portfolio
|
Q4 2024
Reduced 90.92%
|
|
|
Twin Lakes Capital Management, LLC
Redwood Shores, CA |
Feb 18, 2025 Q4 2024 |
266
shares
|
$178,847
0.13% of portfolio
|
Q2 2023
Reduced 8.59%
|
|
|
Wealthpoint, LLC
|
Oct 12, 2023 Q3 2023 |
263
shares
|
$176,830
0.09% of portfolio
|
Q3 2023
Reduced 12.62%
|
|
|
Euclidean Technologies Management, LLC
|
Apr 26, 2023 Q1 2023 |
263
shares
|
$176,830
0.2% of portfolio
|
Q1 2023
New holding
|
|
|
Kelly Lawrence W & Associates Inc
Pasadena, CA |
Feb 13, 2025 Q4 2024 |
263
shares
|
$176,830
0.05% of portfolio
|
Q4 2024
Added 10.5%
|
|
|
Fort, L.P.
Chevy Chase, MD |
Oct 29, 2024 Q3 2024 |
257
shares
|
$172,796
0.7% of portfolio
|
Q3 2024
Reduced 10.76%
|
|
|
Abbrea Capital, LLC
|
Aug 08, 2024 Q2 2024 |
253
shares
|
$170,107
0.04% of portfolio
|
Q2 2024
Reduced 5.6%
|
|
|
Estabrook Capital Management
New York, NY |
Feb 13, 2025 Q4 2024 |
250
shares
|
$168,090
0.03% of portfolio
|
Q3 2023
Reduced 10.71%
|
|
|
Adalta Capital Management LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
245
shares
|
$164,728
0.1% of portfolio
|
Q3 2023
New holding
|
|
|
Syntax Research, Inc.
Boca Raton, FL |
Feb 11, 2025 Q4 2024 |
245
shares
|
$164,728
0.13% of portfolio
|
Q3 2024
Reduced 28.99%
|
|
|
Hamilton Wealth, LLC
|
Nov 14, 2024 Q3 2024 |
240
shares
|
$161,366
0.07% of portfolio
|
Q2 2024
Reduced 47.94%
|
|
|
Cromwell Holdings LLC
Jackson, WY |
Feb 03, 2025 Q4 2024 |
233
shares
|
$156,659
0.1% of portfolio
|
Q2 2024
New holding
|
|
|
Principal Street Partners, LLC
Memphis, TN |
Nov 13, 2024 Q3 2024 |
232
shares
|
$155,987
0.04% of portfolio
|
Q4 2023
New holding
|